Brent Larsen Petersen

Title: Innovations in Glyco-Engineering by Brent Larsen Petersen

Introduction

Brent Larsen Petersen is an innovative inventor based in Roskilde, Denmark. He has made significant contributions to the field of glyco-engineering, particularly in the development of methods for human O-glycosylation in plant cells. His work aims to enhance the production of bioactive glycoproteins and cancer-specific vaccines.

Latest Patents

Brent holds a patent titled "Methods for glyco-engineering plant cells for controlled human O-glycosylation." This invention discloses a novel platform for the recombinant production of bioactive glycoproteins and cancer-specific vaccines in plants. The platform allows for the humanization of plant cell cultures concerning human mucin-type protein O-glycosylation. It provides a basis for producing a wide array of O-glycosylated human glycoprotein therapeutics, including improved cancer vaccine candidates.

Career Highlights

Brent's career is marked by his innovative approach to using plant cells for human O-glycosylation. His research has established the integrity of mucin-type target peptides in plant cells and successfully introduced O-glycosylation through the transient and stable introduction of specific human enzymes and target peptides. This groundbreaking work has the potential to revolutionize the production of therapeutics.

Collaborations

Brent has collaborated with notable coworkers, including Zhang Yang and Damian Paul Drew. Their combined expertise has contributed to the advancement of glyco-engineering techniques and the development of new therapeutic options.

Conclusion

Brent Larsen Petersen's contributions to glyco-engineering represent a significant advancement in biotechnology. His innovative methods for human O-glycosylation in plant cells pave the way for new therapeutic developments and cancer treatments.